Haleon plc (HLN) Financials

HLN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 42.9 billion 21.3 billion
Dec. 31, 2025 43.8 billion 21.7 billion
June 30, 2025 43.7 billion 21.7 billion
March 31, 2025 41.2 billion 20.5 billion

HLN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 1.0 billion ?
Dec. 31, 2025 1.7 billion ?
June 30, 2025 1.4 billion 57.7 million
March 31, 2025 602.3 million 27.2 million

HLN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 1.0 billion
Dec. 31, 2025 1.1 billion
June 30, 2025 1.1 billion
March 31, 2025 521.4 million

HLN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.1 billion 8.1 billion 146.2 million
Dec. 31, 2025 1.8 billion 10.3 billion 178.7 million
June 30, 2025 928.1 million 10.4 billion 181.2 million
March 31, 2025 874.7 million - -

HLN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 5.9 billion
Dec. 31, 2025 6.0 billion
June 30, 2025 6.2 billion
March 31, 2025 5.9 billion

HLN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 146.8 million 196.2 million 3.0 billion -
Dec. 31, 2025 305.9 million 217.7 million 2.9 billion -
June 30, 2025 131.8 million 210.1 million 3.0 billion -
March 31, 2025 62.1 million 99.0 million 1.4 billion -

HLN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 7.5 billion 2.5 billion
Dec. 31, 2025 7.4 billion 2.6 billion
June 30, 2025 7.5 billion 2.7 billion
March 31, 2025 3.5 billion 1.3 billion

HLN

Price: $8.80

52 week price:
8.65
11.28

Dividend Yield: 1.29%

5-year range yield:
1.06%
2.50%

Forward Dividend Yield: 1.46%

Payout Ratio: 33.17%

Payout Ratio Range:
24.41%
91.30%

Dividend Per Share: 0.13 USD

Earnings Per Share: 0.49 USD

P/E Ratio: 20.31

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United Kingdom

Volume: 23.3 million

Market Capitalization: 42.3 billion

Average Dividend Frequency: 2

Years Paying Dividends: 4

Links: